Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 24.00%1.62B | 3.24%930.98M | 4.18%481.06M | -2.77%1.75B | -4.61%1.3B | -3.92%901.76M | 18.87%461.74M | 7.48%1.8B | 6.39%1.37B | 4.20%938.59M |
| Operating revenue | 24.00%1.62B | 3.24%930.98M | 4.18%481.06M | -2.77%1.75B | -4.61%1.3B | -3.92%901.76M | 18.87%461.74M | 7.48%1.8B | 6.39%1.37B | 4.20%938.59M |
| Other operating revenue | ---- | 66.61%34.58M | ---- | -35.14%22.34M | ---- | 22.15%20.75M | ---- | 104.25%34.44M | ---- | 231.87%16.99M |
| Total operating cost | 14.54%1.56B | -2.09%917.14M | -1.54%476.89M | -1.96%1.85B | -3.44%1.36B | -2.04%936.71M | 24.06%484.34M | 11.08%1.88B | 10.80%1.41B | 8.41%956.21M |
| Operating cost | 16.30%1.43B | -1.52%834.64M | -1.33%436.78M | -2.54%1.65B | -3.65%1.23B | -2.14%847.51M | 25.95%442.65M | 12.18%1.69B | 11.32%1.27B | 9.32%866.01M |
| Operating tax surcharges | 50.41%7.03M | 9.70%3.26M | 13.61%1.14M | 27.98%7.95M | 39.25%4.67M | 34.63%2.98M | 18.61%1M | 10.65%6.21M | -8.40%3.35M | -24.35%2.21M |
| Operating expense | -18.53%4.57M | -31.50%2.69M | -18.98%1.27M | -18.73%7.29M | -10.47%5.61M | -2.84%3.93M | -18.88%1.57M | 31.14%8.96M | 11.64%6.27M | 33.81%4.04M |
| Administration expense | -15.40%35.5M | -8.25%25.36M | -9.06%10.87M | 19.66%57.62M | 23.81%41.96M | 21.93%27.65M | 8.20%11.95M | -27.76%48.15M | -36.74%33.89M | -37.06%22.67M |
| Financial expense | -21.06%28.58M | -10.99%20.34M | 4.97%12.08M | -14.92%48.25M | -8.50%36.2M | -10.78%22.85M | 1.36%11.51M | 32.68%56.71M | 86.25%39.57M | 74.82%25.61M |
| -Interest expense (Financial expense) | -28.54%28.39M | -23.90%20.32M | -9.76%11.97M | -7.50%54.38M | -6.46%39.73M | -10.63%26.7M | 28.82%13.26M | 4.85%58.8M | 17.37%42.47M | 15.73%29.88M |
| -Interest Income (Financial expense) | 26.25%-586.54K | 28.82%-459.67K | 20.94%-233.94K | 42.85%-967.24K | 54.51%-795.29K | 80.13%-645.76K | 49.51%-295.91K | 20.60%-1.69M | 72.84%-1.75M | 1.60%-3.25M |
| Research and development | 23.18%58.5M | -3.00%30.84M | -5.82%14.75M | 6.69%77.94M | -13.58%47.49M | -10.86%31.8M | 13.82%15.66M | 9.31%73.06M | 19.90%54.95M | 7.25%35.67M |
| Credit Impairment Loss | -5.72%-2.53M | 8.63%-2.19M | -7,287.85%-1.06M | -236.59%-967.62K | -227.76%-2.4M | -48.58%-2.4M | --14.72K | 189.32%708.39K | -17.98%-731.56K | -29.57%-1.61M |
| Asset Impairment Loss | 81.27%-1.2M | --0 | --0 | 37.11%-31.28M | -1,757.81%-6.42M | -1,757.81%-6.42M | -27.78%1.05M | -99.73%-49.74M | 83.67%-345.31K | 83.67%-345.31K |
| Other net revenue | -80.79%4.96M | -65.11%8.35M | 118.02%4.52M | 106.90%2.37M | 313.69%25.8M | 451.34%23.94M | -47.25%2.07M | -130.93%-34.37M | 50.93%6.24M | 116.17%4.34M |
| Fair value change income | ---- | ---- | ---- | -13,172.97%-713.78K | 2,401.28%136.57K | ---- | ---- | 200.00%5.46K | 100.57%5.46K | 62.91%-149.34K |
| Invest income | 651.67%529.62K | --713.78K | --713.78K | -3,164.90%-1.49M | 45.41%70.46K | --0 | --0 | -81.16%48.46K | -95.42%48.46K | -82.08%132.12K |
| Asset deal income | -98.91%175.17K | -100.14%-22.21K | 98.79%-11.36K | 24,062.77%14.53M | 292,328.06%16.11M | 292,328.06%16.11M | -16,994.67%-942.33K | 438.03%60.12K | ---5.51K | ---5.51K |
| Other revenue | -56.34%7.99M | -40.81%9.85M | 150.48%4.87M | 53.17%22.3M | 151.85%18.3M | 163.22%16.65M | -16.72%1.95M | 52.49%14.56M | 7.35%7.26M | 25.62%6.32M |
| Operating profit | 290.43%61.66M | 301.49%22.19M | 142.34%8.69M | 19.98%-96.07M | 13.73%-32.38M | 17.07%-11.01M | -1,132.64%-20.53M | -217.78%-120.05M | -338.87%-37.53M | -164.13%-13.28M |
| Add:Non operating Income | --113.23K | --113.23K | --3K | 13,000.00%131K | ---- | --0 | --0 | -99.80%1K | ---- | ---- |
| Less:Non operating expense | 495.97%2.33M | 327.00%718.49K | 179.59%430.26K | -92.48%891.17K | -79.58%391.3K | -87.56%168.26K | -22.84%153.89K | 312.33%11.85M | 273.04%1.92M | 393.91%1.35M |
| Total profit | 281.39%59.44M | 293.04%21.58M | 139.96%8.26M | 26.59%-96.83M | 16.93%-32.77M | 23.59%-11.18M | -1,256.42%-20.68M | -228.48%-131.9M | -359.52%-39.45M | -171.61%-14.63M |
| Less:Income tax cost | 2,354.95%7.67M | 484.87%3.2M | -165.89%-38.88K | -163.62%-7.33M | -132.30%-339.99K | -122.56%-830.54K | -34.35%59.01K | -351.13%-2.78M | 115.39%1.05M | 238.84%3.68M |
| Net profit | 259.65%51.77M | 277.65%18.38M | 140.04%8.3M | 30.68%-89.5M | 19.93%-32.43M | 43.48%-10.35M | -1,321.09%-20.74M | -212.93%-129.12M | -283.76%-40.5M | -179.33%-18.31M |
| Net profit from continuing operation | 259.65%51.77M | 277.65%18.38M | 140.04%8.3M | 30.68%-89.5M | 19.93%-32.43M | 43.48%-10.35M | -1,321.09%-20.74M | -212.93%-129.12M | -283.76%-40.5M | -179.33%-18.31M |
| Net profit of parent company owners | 259.65%51.77M | 277.65%18.38M | 140.04%8.3M | 30.68%-89.5M | 19.93%-32.43M | 43.48%-10.35M | -1,321.09%-20.74M | -212.93%-129.12M | -283.76%-40.5M | -179.33%-18.31M |
| Earning per share | ||||||||||
| Basic earning per share | 241.67%0.17 | 250.00%0.06 | 137.50%0.03 | 31.91%-0.32 | 20.00%-0.12 | 42.86%-0.04 | -900.00%-0.08 | -213.33%-0.47 | -287.50%-0.15 | -187.50%-0.07 |
| Diluted earning per share | 241.67%0.17 | 250.00%0.06 | 137.50%0.03 | 31.91%-0.32 | 20.00%-0.12 | 42.86%-0.04 | -900.00%-0.08 | -213.33%-0.47 | -287.50%-0.15 | -187.50%-0.07 |
| Other composite income | ||||||||||
| Total composite income | 259.65%51.77M | 277.65%18.38M | 140.04%8.3M | 30.68%-89.5M | 19.93%-32.43M | 43.48%-10.35M | -1,321.09%-20.74M | -212.93%-129.12M | -283.76%-40.5M | -179.33%-18.31M |
| Total composite income of parent company owners | 259.65%51.77M | 277.65%18.38M | 140.04%8.3M | 30.68%-89.5M | 19.93%-32.43M | 43.48%-10.35M | -1,321.09%-20.74M | -212.93%-129.12M | -283.76%-40.5M | -179.33%-18.31M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Guangdong Sinong Accounting Firm (Special General Partnership) | -- | -- | -- | Guangdong Sinong Accounting Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.